Literature DB >> 7701199

Psychosocial impact of narcolepsy.

W A Broughton1, R J Broughton.   

Abstract

Despite remarkable progress in our understanding of narcolepsy, the disease continues to cause the sufferer severe negative life effects. Before and after diagnosis, narcoleptics often experience unrelenting severe psychosocial stress. Child and adolescent narcoleptics report embarrassment, academic decline and feelings of loss of self-worth related to the symptoms of their disease. Personality characteristics may be adapted in order to avoid social situations that would precipitate cataplexy or draw attention to the patient's degree of somnolence. Misdiagnosis of these illnesses may result in inappropriate treatment and underestimation of an individual's potential. Adult narcoleptics also face the concerns of the workplace. Worry about loss of job and income are a source of anxiety and are often based in reality. Accidents at home, while driving and in the workplace are increased, creating safety concerns for both the patient and the community. Marital difficulties are common and psychopathology is known to occur more frequently. Narcolepsy's marked impact on quality of life has been found to be similar across cultural lines and these effects appear to be an inherent part of the disease. The socioeconomic impact in general is even more severe than those of comparable forms of epilepsy. Successful diagnosis and treatment do not end the narcoleptic's difficulties. The need for stimulants often creates problems with pharmacists and family. Somnolence, which responds the most poorly of all narcoleptic symptoms, leads to continued problems in the workplace. Side effects related to stimulant use may be a further source of difficulty. Finally, families may be unwilling to accept the illness and thereby alienate the patient.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 7701199     DOI: 10.1093/sleep/17.suppl_8.s45

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  22 in total

1.  Narcolepsy.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-09       Impact factor: 3.598

Review 2.  Cataplexy associated with narcolepsy: epidemiology, pathophysiology and management.

Authors:  Michael J Thorpy
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 3.  Narcolepsy: immunological aspects.

Authors:  Sebastiaan Overeem; John Logan Black; Gert Jan Lammers
Journal:  Sleep Med Rev       Date:  2008-03-04       Impact factor: 11.609

4.  Psychosocial Profile and Quality of Life in Children With Type 1 Narcolepsy: A Case-Control Study.

Authors:  Francesca Letizia Rocca; Elena Finotti; Fabio Pizza; Francesca Ingravallo; Michela Gatta; Oliviero Bruni; Giuseppe Plazzi
Journal:  Sleep       Date:  2016-07-01       Impact factor: 5.849

5.  The narcoleptic syndrome.

Authors:  J D Parkes; S J Clift; M J Dahlitz; S Y Chen; G Dunn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-09       Impact factor: 10.154

6.  Reward-seeking behavior in human narcolepsy.

Authors:  Alexandra Dimitrova; Rolf Fronczek; Janneke Van der Ploeg; Thomas Scammell; Shiva Gautam; Alvaro Pascual-Leone; Gert Jan Lammers
Journal:  J Clin Sleep Med       Date:  2011-06-15       Impact factor: 4.062

7.  The Humanistic and Economic Burden of Narcolepsy.

Authors:  Natalia M Flores; Kathleen F Villa; Jed Black; Ronald D Chervin; Edward A Witt
Journal:  J Clin Sleep Med       Date:  2016-03       Impact factor: 4.062

8.  Modafinil : A Review of its Pharmacology and Clinical Efficacy in the Management of Narcolepsy.

Authors:  K J McClellan; C M Spencer
Journal:  CNS Drugs       Date:  1998-04       Impact factor: 5.749

Review 9.  Benefits and risks of pharmacotherapy for narcolepsy.

Authors:  Merrill M Mitler; Roza Hayduk
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

10.  Factors associated with duration before receiving definitive diagnosis of narcolepsy among Japanese patients affected with the disorder.

Authors:  Yoichiro Ueki; Kenichi Hayashida; Yoko Komada; Masaki Nakamura; Mina Kobayashi; Makio Iimori; Yuichi Inoue
Journal:  Int J Behav Med       Date:  2014-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.